Myocardial infarction in a canine model monitored by two-dimensional 31P chemical shift spectroscopic imaging

Magnetic Resonance in Medicine

Volumn 38, Issue 4, 1997, Pages 577-584

  Farrall, Andrew J ^b   Thompson, R Terry ^a,b,c   Wisenberg, Gerald ^a   Campbell, Constance M ^b   Drost, Dick J ^a,b  

^a LAWSON HEALTH RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

^c ST JOSEPH S HEALTH CENTRE   (Canada)

Author keywords

Blood flow; Gadolinium enhanced images; Myocardial infarction; Phosphorus MRS

Indexed keywords

ADENOSINETRIPHOSPHATE; CARDIOLOGY; CHEMICAL SHIFT; HEMODYNAMICS; IMAGE ENHANCEMENT; METABOLISM; METABOLITES; MICROSPHERES; PHOSPHATES; RISK ASSESSMENT;

BLOOD FLOW; CHEMICAL SHIFT IMAGING; HIGH ENERGY PHOSPHATES; LEFT ANTERIOR DESCENDING; MYOCARDIAL INFARCTION; NON-INVASIVE MONITORING; PARTITION COEFFICIENT; RADIOACTIVE MICROSPHERES;

BLOOD;

ADENOSINE TRIPHOSPHATE; CREATINE PHOSPHATE; GADOLINIUM PENTETATE; PHOSPHATE; RADIOACTIVE MICROSPHERE; SCANDIUM 46; STRONTIUM 85;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DOG; FEMALE; HEART INFARCTION; HEART MUSCLE BLOOD FLOW; INTRACARDIAC DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LEFT ANTERIOR DESCENDING CORONARY ARTERY; NONHUMAN; PARTITION COEFFICIENT; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; PROTON NUCLEAR MAGNETIC RESONANCE;

EID: 0030882797     PISSN: 07403194     EISSN: None     Source Type: Journal    
DOI: 10.1002/mrm.1910380412     Document Type: Article

References (58)

1. R. D. Bing, Metabolic activity of the intact heart. Am. J. Med. 30, 679-691 (1981).
2. 31P nuclear magnetic resonance and ventricular function following graded cardiac ischemia. Curr. Surg. 41, 90-91 (1984).
3. 31P nuclear magnetic resonance. Surgery 97, 428-435 (1984).
4. C. E. Jones, J. X. Thomas, J. C. Parker, A. C. Parker, Acute changes in high energy phosphates: nucleotide derivatives and contractile force in ischemic and non-ischemic canine myocardium following coronary occlusion. Cardiovasc. Res. 10, 276-282 (1976).
5. G. Ambrosio, M. Weisfeldt, W. E. Jacobus, J. T. Flaherty, Evidence for a reversible oxygen-free radical mediated component of reperfusion injury: reduction by recombinant human superoxide dismutase administered at the time of reflow. Circulation 75, 282-291 (1987).
6. S. A. Camacho, W. W. Parmley, T. L. James, H. Abe, S. T. Wu, E. H. Botvinick, T. A. Watters, N. Schieler, K. Sievers, J. Wilkman-Coffelt, Substrate regulation of the nucleotide pool during regional ischemia and reporfusion in an isolated rat heart preparation: a phosphorus-31 magnetic resonance spectroscopic analysis. Cardiovasc. Res. 22, 193-203 (1988).
7. 31P nuclear magnetic resonance. J. Cardiov. Pharmacol. 5, 1040-1047 (1983).
8. 31P NMR in the isolated perfused rat heart, Jpn. J. Pharmacol. 39, 51-58 (1985).
9. S. Ochi, Y. Ogawa, H. Imai, M. Nakazawa, S. Imai, Effects of beta blockers on the fall of pH in the early phase of ischemia in the isolated perfused rat heart: a nuclear magnetic resonance study. J. Cardiovasc. Pharmacol. 11, 326-331 (1988).
10. T. D. Scholz, M. Grover-McKay, S. R. Fleagle, D. J. Skorton, Quantitation of the extent of myocardial infarction by phosphorous-31 nuclear magnetic resonance spectroscopy. J. Am. Coll. Cardiol. 18, 1380-1387 (1991).
11. 31P magnetic resonance spectroscopy study. Am. Heart J. 116, 701-708 (1988).
12. B. D. Guth, J. F. Martin, G. Heushe, J. Ross, Regional myocardial blood flow, function and metabolism using phosphorus-31 nuclear magnetic resonance spectroscopy during ischemia and reperfusion in dogs. J. Am. Coll. Cardiol. 10, 673-681 (1987).
13. L. A. Katz, J. A. Swain, P. A. Portman, R. S. Balaban, Relation between phosphate metabolites and oxygen consumption of heart in vivo. Am. J. Physiol. 256, H265-H274 (1989).
14. K. M. Kavanaugh, A. M. Aisen, K. P. Fechner, T. L. Chenevert, W. R. Dunham, A. J. Buda, Regional metabolism during coronary occlusion, reperfusion and re-occlusion using phosphorous-31 nuclear magnetic resonance spectroscopy in the intact rabbit. Am. Heart J. 117, 53-59 (1989)
15. C. R. Malloy, P. M. Mathews, M. B. Smith, G. K. Radda, Influence of propranolol on acidosis and high energy phosphates in ischemic myocardium of the rabbit. Cardiovasc. Res. 20, 710-720 (1986).
16. K. J. Neurohr, R. G. Shulman, Carbon-13 and phosphorus-31 nuclear magnetic resonance studies of myocardial metabolism in live guinea pigs. Adv. Myocardial. 6, 185-195 (1985).
17. 31P MRS. Magn. Res. Med. 7, 172-183 (1988).
18. L. C. Wroblewski, A. M. Aisen, S. D. Swanson, A. J. Buda, Evaluation of myocardial viability following ischemic and reperfusion injury using phosphorus 31 nuclear magnetic resonance spectroscopy in vivo. Am. Heart J. 120, 31-39 (1990).
19. R. B. Rehr, B. E. Fuhs, F. Lee, J. L. Tatum, J. I. Hirsch, R. Quint, Differentiation of reparfused-viable (stunned) from reperfused-infarcted myocardium at 1 to 3 days post reperfusion by in vivo phosphorus-31 nuclear magnetic resonance spectroscopy. Am. Heart J. 122, 1571-1582 (1991).
20. P. A. Bottomley, L. S. Smith, S. Brazzamano, L. W. Hedlund, R. W. Redington, R. J. Herfkens, The fate of inorganic phosphate and pH in regional myocardial ischemia and infarction: a noninvasive P-31 NMR study. Magn. Reson. Med. 5, 129-142 (1991).
21. R. A. Robb, A software system for interactive and quantitative analysis of biomedical images in 3D imaging in medicine. NATO ASI Ser. F 60, 333-361 (1990).
22. C. Y. Tong, F. S. Prato, G. Wisenberg, T. Y. Lee, E. Carroll, D. Sandier, J. Wills, D. J. Drost, Measurement of the extraction efficiency and distribution volume for Gd-DTPA in normal and diseased canine myocardium. Magn. Reson. Med. 30, 337-346 (1993).
23. R. B. Rehr, G. Clarke, J. Tatum, J. Hirsch, P. Fatouros, R. Lower, L. Wetstein, Intracellular myocardial pH measured in vivo with sustained and reperfused coronary occlusion. Surgery 102, 178-185 (1987).
24. R. B. Rehr, J. L. Tatum, J. I. Hirsch, R. Qunt, G. Clarke, Reperfusedviable and reperfused-infarcted myocardium: differentiation with in vivo P-31 MR spectroscopy. Radiology 172, 53-58 (1989).
25. S. J. W. Busby, D. G. Gadian, G. K. Radda, R. E. Richards, P. J. Seeley, Phosphorus NMR studies of compartmentation in muscle. Biochem. J 170, 103-114 (1978).
26. S. Schaefer, G. G. Schwartz, J. R. Gober, A. K. Wong, S. A. Camach, B. Massie, M. W. Weiner, Relationship between myocardial metabolites and contractile abnormalities during graded regional ischemia. J. Clin. Invest. 85, 706-713 (1990).
27. S. Schaefer, G. G. Schwartz, J. R. Gober, B. Massie, M. W. Weiner, Magnetic resonance spectroscopy evaluation of ischemic heart disease. Invest. Radiol. 24, 969-972 (1989).
28. 31P NMR spectroscopy of porcine myocardium in vivo. Circ. Res. 64, 968-976 (1989).
29. R. B. Rehr, J. L. Tatum, J. I. Hirsch, L. Wetstein, G. Clarke, Effective separation of normal acutely ischemic and reperfused myocardium with P-31 MR spectroscopy. Radiology 168, 81-89 (1988).
30. D. M. Yellon, D. J. Hearse, R. Crome, R. K. H. Wyse, Characterization of the lateral interface between normal and ischemic tissue in the canine heart during evolving myocardial infarction. Am. J. Cardiol. 47, 1233-1239 (1981).
31. B. I. Judgutt, G. M. Hutchins, B. H. Bulkloy, L. C. Becker, Myocardial infarction in the conscious dog: three-dimensional mapping of infarct, collateral flow and region at risk. Circulation 60, 1141-1150 (1979).
32. E. M. Okun, S. M. Factor, E. S. Kirk, End-capillary loops in the heart: an explanation for discrete myocardial infarctions without border zones. Science 206, 565-572 (1979).
33. D. J. Hearse, D. M. Yellon, The "border zone" in evolving myocardial infarction: controversy or confusion? Am. J, Cordial. 47, 1321-1334 (1981).
34. R. H. Murdoch, D. M. Harlan, J. J. Morris, W. W. Pryor, F. R. Cobb, Transitional blood flow zones between ischemic and non-ischemic myocardium in the awake dog. Cire. Res. 52, 451-459 (1983).
35. J. E. Lowe, K. A. Reimer, R. B. Jennings, Experimental infarct size as a function of the amount of myocardium at risk. Am. J. Pathol. 90, 303-380 (1977).
36. W. Schaper, Experimental coronary artery occlusion. III. The determinants of collateral blood flow in acute coronary occlusion. Basic Res. Cardiol. 73, 584-594 (1978).
37. D. M. Yellon, D. J. Hearse, M. P. Maxwell, D. E. Chambers, J. M. Downey, Sustained limitation of myocardial necrosis 24 hours after coronary artery occlusion: verapramil infusion in dugs with small myocardial infarcts. Am. J. Cardiol. 51, 1409-1413 (1983).
38. R. B. Dunn, D. M. Griggs, Transmural gradients in ventricular tissue metabolites produced by stopping coronary blood flow in the dog, Circ. Res. 37, 438-445 (1975).
39. R. B. Jennings, H. K. Hawkins, J. E. Lowo, M. L. Hill, S. Klotman, K, A. Reimer, Relation between high energy phosphate and lethal injury in myocardial ischemia in the dog. Am. J. Pathol. 92, 187-214 (1978).
40. P. S. Puri, Contractile and biochemical effects of coronary reperfusion after extended periods of coronary occlusion. Am. J. Cardiol. 36, 244-251 (1975).
41. I. A. Bailey, G. K. Radda, A. L. Seymour, S. R. Williams, The effects of insulin on myocardial metabolism and acidosis in normoxia and ischemia. Biochim. Biophys. Acta 720, 17-27 (1982).
42. J. T. Flaherty, M. L. Weisfeldt, B. H. Bulkley, T. J. Gardner, V. L. Gott, W. E. Jacobus, Mechanisms of ischemic myocardial cell damage assessed by phosphorus-31 nuclear magnetic resonance. Circulation 65, 581-571 (1982).
43. M. L. Murphy, C. F. Peng, J. J. Kane, K. D. Straub, Ventricular performance and biochemical alteration of regional ischemic myocardium after reperfusion in the pig. Am. J. Cardiol. 50, 821-828 (1982).
44. 2+ metabolism following total and partial myocardial ischemia. Am. Heart J. 112, 1238-1244 (1986).
45. K. A. Reimer, M. K. Hill, R. B. Jennings, Prolonged depletion of ATP and of the adenine nucleotide pool due to delayed resynthesis of adenine nucleotides following reversible myocardial ischemic injury in dogs. J. Mol. Cell. Cardiol. 13, 229-239 (1981).
46. S. G. Ellis, C. I. Henschke, T. Sandor, J. Wynne, E. Braunwald, R. A. Kloner, Time course of functional and biochemical recovery of myocardium salvaged by reperfusion. J. Am. Coll. Cardiol. 1, 1047-1055 (1983).
47. M. A. Brown, D. W. Myears, P. Herrero, S. R. Bergmann, Disparity between oxidative and fatty acid metabolism in reperfused myocardium assessed with positron emission tomography. Circulation 76(Suppl. IV), IV-4 (1987).
48. M. Schwaiger, H. R. Schelbert, R. Keen, J. Vinten-Johanson, H. Hansen, C. Selin, J. Barrio, S. C. Huang, M. E. Phelps, Retention and clearance of C-11 palmitic acid in ischemic and reperfused canine myocardium. J. Am. Coll. Cardiol. 6, 311-320 (1985).
49. R. Lange, R. A. Kloner, M. Zierler, N. Carlson, M. Zeirler, S. F. Khuri, Time course of ischemic alterations during normothermic and hypothermic arrest and its reflection by on-line monitoring of tissue pH. J. Thorac. Cardiovasc. Surg. 86, 418-434 (1983).
50. S. F. Khuri, M. Josa, W. Marston, N. S. Braunwald, B. Smith, D. Tow, M. VanCisin, E. M. Barsamian, First report of intramyocardial pH in man. II. Assessment of adequacy of myocardial preservation, J. Thorac. Cardiovasc. Surg. 86, 667-678 (1983).
51. T. J. Takach, L. R. Glassman, A. L. Milewicz, R. E. Clark, Continuous measurement of intramyocardial pH: relative importance of hypothermia and cardioplegic perfusion pressure and temperature. Ann. Thorac. Surg. 42, 365-371 (1986).
52. F. J. M. Walters, G. J. Wilson, D. J. Steward, R. J. Domenech, D. C. MacGregor, Intramyoeardial pH as an index of myocardial metabolism during cardiac surgery. J. Thorac. Cardiovasc. Surg. 78, 319-330 (1979).
53. L. C. Stewart, R.A Kelly, D. E. Atkinson, L. S. Ingwall, pH heterogeneity in aged hypertensive rat hearts distinguishes reperfused from persistently ischemic myocardium. J. Mol Cell. Cadiol. 27, 321-333 (1995).
54. S. F. Khuri, R. A. Kloner, S. A. Karaffe, W. Marston, A. D. Taylor, N. C. J. Lai, D. E. Tow, E. M. Barsamian, The significance of the late fall in myocardial PC02 and its relationship to myocardial pH after regional coronary occlusion in the dog. Circ. Res. 56, 537-547 (1985).
55. 31P NMR spectroscopy. NMR Biomed. 1, 177-182 (1989).
56. R. Zahler, S. Majumdar, B. Frederick, M. Laughlin, E. Barrett, J. C. Gore, NMR determination of myocardial pH in vivo: separation of tissue inorganic phosphate from blood 2,3-DPG. Magn. Res. Med. 17, 368-378 (1991).
57. 31P chemical-shift imaging. J. Magn. Res. Ser. B 104, 199-211 (1994).
58. 31P spectroscopic imaging of the human heart at 4.1 T. Magn. Res. Mad. 33, 427-431 (1995).